Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01094054 · ClinicalTrials.gov registry record · Phase 4
Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT01094054: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT01094054 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01094054, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
The overall aim is to determine the mechanism(s) by which common bariatric surgical procedures alter carbohydrate metabolism. Understanding these mechanisms may ultimately lead to the development of novel interventions for the prevention and treatment of Type 2 diabetes and obesity.
Interventions
- PROCEDURE Adjustable gastric banding
- BEHAVIORAL Dietary and lifestyle modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01094054
The ClinicalTrials.gov registry entry for NCT01094054 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adjustable gastric banding is the first listed.
NCT01094054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01094054 about?
NCT01094054 is a clinical study titled "Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss". The overall aim is to determine the mechanism(s) by which common bariatric surgical procedures alter carbohydrate metabolism. Understanding these mechanisms may ultimately lead to the development of novel interventions for the prevention and treatment of Type 2 diabetes and obesity.
What is the current status of trial NCT01094054?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2010-10. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01094054?
The interventions under investigation include: Adjustable gastric banding (PROCEDURE), Dietary and lifestyle modification (BEHAVIORAL).
Who is sponsoring clinical trial NCT01094054?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.